Where do Kalaris Therapeutics, Inc. Common Stock's ratios come from?

Every ratio is computed from Kalaris Therapeutics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Returns
Return on assets	-67.9%+2.3pp	-70.2%+11.2pp	-81.4%—	——
Liquidity
Current ratio	12.2×+12.1×	0.1×-6.5×	6.6×-3.4×	10×+3.3×
Quick ratio	12.2×+12.1×	0.1×-6.5×	6.6×-3.4×	10×+3.3×
Cash ratio	10.1×+10.0×	0.1×-3.1×	3.2×-1.2×	4.4×-1.0×
Leverage
Debt-to-equity	0×—	——	——	0.2×0.0×
Debt-to-assets	0×—	——	0.1×0.0×	0.1×0.0×
Interest coverage	-32×-12.8×	-19.2×—	——	——
Per Share
Book value per share	$5.16+107%	-$72.32-627%	-$9.95-440%	$2.93-18.4%
Valuation
Market capitalization	$96.83M+136%	——	——	——
Enterprise value	$63.82M—	——	——	——
Price / book	1.6×+0.7×	——	——	——
Earnings yield	-39%+132pp	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Kalaris Therapeutics, Inc. Common Stock's ratios come from?: Every ratio is computed from Kalaris Therapeutics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.